Tirofiban+Oral Dual Antiplatelet Therapy

DRUG2 trials

Sponsors

Second Affiliated Hospital of Soochow University, First Affiliated Hospital of Fujian Medical University

Conditions

Mild StrokeRuptured Intracranial AneurysmsSubarachnoid Hemorrhage, Aneurysmal

Phase 3

The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of Ruptured Intracranial Aneurysms With Stent

Not yet recruitingNCT07818083

First Affiliated Hospital of Fujian Medical UniversityRuptured Intracranial Aneurysms, Subarachnoid Hemorrhage, Aneurysmal

Start: 2026-09-01End: 2028-12-31Target: 622Updated: 2026-09-14

Phase 4

Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke

RecruitingNCT07095790

Second Affiliated Hospital of Soochow UniversityMild Stroke

Start: 2025-08-30End: 2027-05-31Target: 580Updated: 2025-07-31

Related Papers

Tirofiban with sequential dual antiplatelet therapy in mild acute ischemic stroke (TiMIS): protocol for a multicenter, randomized controlled trial

Figshare2026-03-16

Tirofiban with sequential dual antiplatelet therapy in mild acute ischemic stroke (TiMIS): protocol for a multicenter, randomized controlled trial

Figshare2026-03-16

Tirofiban with sequential dual antiplatelet therapy in mild acute ischemic stroke (TiMIS): protocol for a multicenter, randomized controlled trial.

2026-03-15